PHARMACOSMOS HOLDING A/S: Financial statements 2019
CVR: 69720919
Source: annual report 2019, Danish Business Authority
01/05/2018 – 30/04/2019
PHARMACOSMOS HOLDING A/S (CVR 69720919) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 2,803,000 and a net result of DKK 97,219,000 compared with DKK 51,639,000 the year before. That is a decrease of 2.4% compared with the year before. The profit margin was 3,468.4%. Equity in the 2019 report amounted to DKK 888,723,000. The solvency ratio was 99%. The company had 236 employees in the financial year.
- Revenue
- DKK 2,803,000
- Gross Profit
- DKK 205,000
- Profit/Loss
- DKK 97,219,000
- Equity
- DKK 888,723,000
- Total Assets
- DKK 898,000,000
- Employees
- 236
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 2.8M | 205K | 97.2M | 888.7M | 236 |
| 2018 | 2.9M | 749K | 51.6M | 873.4M | 208 |
| 2017 | 2.4M | 305K | 155M | 876.9M | 172 |
| 2016 | 2.2M | 160K | 90.5M | 745.6M | 142 |
| 2015 | 2.7M | 3.2M | 98.7M | 680.9M | 134 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of February 8, 2019, Jacob Tolstrup has joined the board of directors of PHARMACOSMOS HOLDING A/S.
As of February 8, 2019, Axel Kierkegaard has left the board of directors of PHARMACOSMOS HOLDING A/S.
About PHARMACOSMOS HOLDING A/S
PHARMACOSMOS HOLDING A/S is a Danish company of the type Aktieselskab based in Holbæk, founded in 1965. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named PHARMACOSMOS A/S. The management consists of Tobias Sidelmann Christensen and Henrik Parker. The board consists of Lars Christensen (chair), Henrik Parker and Milena Jordanova Olsen. The company is owned by Medicosmos A/S. The company has 1 employee (2022). In 2026, the company reported revenue of DKK 63,000,000 and a net result of DKK 756,000,000 compared with DKK 1,652,000,000 the year before. Equity in the 2026 report amounted to DKK 3,044,000,000.
